FCB Halesway

News

FCB Health has expanded its global footprint, opening a new office in Frankfurt and bringing its network ambassadors model to Amsterdam and Zurich.

News

FCB Health has evolved its Hudson Global agency into a new offering that will be under the leadership of its Area 23 communications agency.

News

Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.